Search Results
Pre-clinical results on naproxcinod in models of muscular dystrophy presented at MDA Scientific Conference
SOPHIA ANTIPOLIS, FRANCE--(Marketwired - Apr 23, 2013) - Nicox S.A. (EURONEXT PARIS: COX) today announced promising pre-clinical results on naproxcinod, a CINOD (Cyclooxygenase-Inhibiting Nitric Oxide-Donating) anti-inflammatory candidate, in models of muscular dystrophies